<DOC>
	<DOC>NCT00253266</DOC>
	<brief_summary>This is an assessment of the efficacy of venlafaxine-HCL augmentation with the neuroleptic quetiapine in treatment resistant depression.</brief_summary>
	<brief_title>Venlafaxine Augmentation in Treatment Resistant Depression</brief_title>
	<detailed_description>We examine the efficacy of Venlafaxine-HCL augmentation with the neuroleptic Quetiapine in treatment resistant depression in a double-blind randomized clinical trial. Secondary objective is the evaluation of pharmacogenetic factors contributing to drug efficacy in treatment resistant depression.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Female and male inpatients with a major depressive disorder without psychotic features or with a depressive episode within a bipolar I or II disorder without psychotic features Ages between 20 and 70 years Total score greater than 18 on the Hamilton Depression Rating Scale Documentation of at least one ineffective antidepressant drug trial under adequate dosage for at least 6 weeks in the current episode Other psychiatric axis I disorders than those mentioned as Inclusion criteria Acute suicidality (Item 3 of the Hamilton Depression Rating Scale greater than 2) Drug or alcohol addiction Patients with severe hepatic, cardiovascular, neurologic, metabolic or malignant disorders Documentation or report of a previous ineffective treatment trial with venlafaxine, lamotrigine or quetiapine Functional kidney disorders Untreated hypertension Acute treatment with thyroid hormone (less than 3 months) Pregnant or nursing patients Women of childbearing age without effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Treatment resistant depression</keyword>
	<keyword>Augmentation</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>